Brief: Sk Bioscience's Zoster Vaccine Receives Biologics License Application Approval In Malaysia
09/01/2023 13:39
SK Bioscience Co Ltd 302440.KS :
* SK BIOSCIENCE'S ZOSTER VACCINE RECEIVES BIOLOGICS LICENSE
APPLICATION APPROVAL IN MALAYSIA
Source text for Eikon: ID:nPn41VydZa
Further company coverage: 302440.KS
Recent news on SK bioscience
See all newsBrief: Sk Bioscience Co Wins 23.9 Billion Won Order
Brief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate